Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2006 4
2007 1
2008 1
2009 5
2010 5
2011 6
2012 3
2013 1
2014 4
2015 2
2016 3
2017 7
2018 8
2019 14
2020 6
2021 2
2022 3
2023 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association.
Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Führer D, Giovanella L, Greenspan B, Luster M, Muylle K, Smit JWA, Van Nostrand D, Verburg FA, Hegedüs L. Tuttle RM, et al. Among authors: van nostrand d. Thyroid. 2019 Apr;29(4):461-470. doi: 10.1089/thy.2018.0597. Thyroid. 2019. PMID: 30900516
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version.
Avram AM, Giovanella L, Greenspan B, Lawson SA, Luster M, Van Nostrand D, Peacock JG, Ovčariček PP, Silberstein E, Tulchinsky M, Verburg FA, Vrachimis A. Avram AM, et al. Among authors: van nostrand d. J Nucl Med. 2022 Jun;63(6):15N-35N. J Nucl Med. 2022. PMID: 35649660 Free article. No abstract available.
The Martinique Principles.
Ahuja S, Avram AM, Dillehay G, Greenspan BS, Gulec S, Van Nostrand D. Ahuja S, et al. Among authors: van nostrand d. J Nucl Med. 2019 Sep;60(9):1334-1335. doi: 10.2967/jnumed.119.232066. Epub 2019 Jun 21. J Nucl Med. 2019. PMID: 31227575 Free article. No abstract available.
Radioiodine refractory differentiated thyroid cancer.
Jin Y, Van Nostrand D, Cheng L, Liu M, Chen L. Jin Y, et al. Among authors: van nostrand d. Crit Rev Oncol Hematol. 2018 May;125:111-120. doi: 10.1016/j.critrevonc.2018.03.012. Epub 2018 Mar 22. Crit Rev Oncol Hematol. 2018. PMID: 29650270 Review.
Brief progress report from the intersocietal working group on differentiated thyroid cancer.
Verburg FA, Ahuja S, Avram AM, Bardiès M, Bernet V, Bourguet P, Führer-Sakel D, Draganescu C, Daniels GH, Greenspan B, Gulec S, Hegedüs L, Jonklaas J, Luster M, Oyen W, Smit J, Tuttle RM, Zerdoud S, Van Nostrand D. Verburg FA, et al. Among authors: van nostrand d. Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1345-1347. doi: 10.1007/s00259-020-04744-8. Eur J Nucl Med Mol Imaging. 2020. PMID: 32166513 Free PMC article. No abstract available.
Advanced differentiated thyroid cancer: when to stop radioiodine?
Giovanella L, van Nostrand D. Giovanella L, et al. Among authors: van nostrand d. Q J Nucl Med Mol Imaging. 2019 Sep;63(3):267-270. doi: 10.23736/S1824-4785.19.03191-1. Epub 2019 Jul 1. Q J Nucl Med Mol Imaging. 2019. PMID: 31271271 Review.
Radioiodine treatment of well-differentiated thyroid cancer.
Wartofsky L, Van Nostrand D. Wartofsky L, et al. Among authors: van nostrand d. Endocrine. 2012 Dec;42(3):506-13. doi: 10.1007/s12020-012-9729-5. Epub 2012 Jun 26. Endocrine. 2012. PMID: 22733393 Review. No abstract available.
David C. Moses, MD (1940-2020).
Van Nostrand D. Van Nostrand D. J Nucl Med. 2020 Jun;61(6):20N. J Nucl Med. 2020. PMID: 32499287 Free article. No abstract available.
75 results